It seems we can’t find what you’re looking for. Perhaps searching can help.
1843 - 1956
London Health Sciences Centre – A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors